Specific cytokines, like IL-1 beta, though significant, seem to play a relatively smaller role in the inflammatory mechanisms of RA compared to TNF and IL-6.18 This is evident in the limited clinical efficacy observed with anakinra, an IL-1 receptor antagonist, in RA treatment.18 This evidence concerns the gene IL1B and rheumatoid arthritis.